Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;9(Suppl 2):S186-S194.
doi: 10.21037/tau.2019.11.03.

Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature

Alexander J Tatem  1 , Levi C Holland  2 , Jason Kovac  1 , Jonathan A Beilan  3 , Larry I Lipshultz  4
Affiliations
Review

Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature

Alexander J Tatem et al. Transl Androl Urol. 2020 Mar.

Abstract

Testosterone is an archetypal androgenic-anabolic steroid (AAS), while its exogenous administration is considered to be the gold standard for the treatment of male hypogonadism. The benefits are not due to its intrinsic nature alone but are due to the result of its interactions with the androgen receptor (AR). As the management of hypogonadism continues to advance into the modern era, it would be preferable for modern andrologists to have multiple tools at their disposal to influence AR activity. Nandrolone, or 19-nortestosterone, is one such compound. In the following review of the literature, we examine the history, pharmacology, and clinical applications of this medication. We also present the results of our novel pilot study examining the favorable effects of nandrolone on joint pain for hypogonadal men.

Keywords: Nandrolone; andrology; arthritis; hypogonadism; joint pain; testosterone; testosterone deficiency.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The focused issue “Contemporary Issues and Controversies in Men’s Health” was commissioned by the editorial office without any funding or sponsorship. LIL serves as an unpaid editorial board member of Translational Andrology and Urology from Nov 2019 to Oct 2021 and served as the unpaid Guest Editor of the focused issue. Dr. Kovac: Abbvie (Consultant). Dr. Lipshultz: American Medical Systems (Speaker); AbbVie (Consultant); Lipocine (Consultant); Aytu Bioscience (Consultant); Endo Pharmaceuticals (Speaker/Consultant). The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Comparative organic structure of testosterone and nandrolone (13).
Figure 2
Figure 2
Mean RAPS scores before and after ND treatment. *, P<0.05. RAPS, Rheumatoid Arthritis Pain Scale; ND, nandrolone decanoate; SD, standard deviation.
See this image and copyright information in PMC

References

    1. Dohle GR, Arver S, Bettocchi C, et al. EAU guidelines on male hypogonadism. 2016. Available online: https://uroweb.org/wp-content/uploads/EAU-Guidelines-Male-Hypogonadism-2...
    1. Corona G, Maggi M. The role of testosterone in erectile dysfunction. Nat Rev Urol 2010;7:46-56. 10.1038/nrurol.2009.235 - DOI - PubMed
    1. Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013;369:1011-22. 10.1056/NEJMoa1206168 - DOI - PMC - PubMed
    1. Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639-50. 10.1210/jc.2009-1251 - DOI - PubMed
    1. Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005;63:280-93. 10.1111/j.1365-2265.2005.02339.x - DOI - PubMed